» Articles » PMID: 20880580

A Peptide-based Material Platform for Displaying Antibodies to Engage T Cells

Overview
Journal Biomaterials
Date 2010 Oct 1
PMID 20880580
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

This study investigated a strategy by which antibodies are displayed to engage T cells. A peptide composite containing binding sites was characterized in vitro and explored as an injectable system in vivo. The composite consists of two amphiphilic peptides, AEAEAKAKAEAEAKAK (referred to as "EAK") and EAK appended with six consecutive histidines at the C-terminus ("EAKH6"). Spectroscopic analysis showed the two peptides integrated into a single structure. Prior to combination, conformational analysis revealed that EAKH6 adopts a mixed α-helix/β-strand conformation. In the presence of EAK, EAKH6 exists predominately in β-strand conformation. The composite of EAK-EAKH6 was found to display His-tags, using nickel-bound horseradish peroxidase as a probe. T cell-specific antibodies were found stably displayed on the EAK-EAKH6 assembly using recombinant protein A/G and anti-histidines antibody as an adaptor. When mounted with anti-CD4 antibody, the system was shown to capture CD4T cells in a mixed population of lymphocytes. Antibodies were concentrated in the subcutaneous space in mice when co-administered with EAK and EAKH6 along with protein A/G and anti-histidines antibody as a solution. We report here the use of amphiphilic peptides to display Ab in vivo, the results indicating that the design can be used as a platform for engaging specific subsets of leukocytes for the purpose of immune modulation.

Citing Articles

Fibril-Guided Three-Dimensional Assembly of Human Fibroblastic Reticular Cells.

Velankar K, Liu W, Hartmeier P, Veleke S, Reddy G, Clegg B ACS Appl Bio Mater. 2024; 7(6):3953-3963.

PMID: 38805413 PMC: 11190984. DOI: 10.1021/acsabm.4c00331.


Advancements in self-assembling peptides: Bridging gaps in 3D cell culture and electronic device fabrication.

Jafari A J Biomater Appl. 2024; 38(10):1013-1035.

PMID: 38502905 PMC: 11055414. DOI: 10.1177/08853282241240139.


IgG Fc Affinity Ligands and Their Applications in Antibody-Involved Drug Delivery: A Brief Review.

Yang C, He B, Zhang H, Wang X, Zhang Q, Dai W Pharmaceutics. 2023; 15(1).

PMID: 36678816 PMC: 9862274. DOI: 10.3390/pharmaceutics15010187.


EGFR Targeted Cetuximab-Valine-Citrulline (vc)-Doxorubicin Immunoconjugates- Loaded Bovine Serum Albumin (BSA) Nanoparticles for Colorectal Tumor Therapy.

Ye Z, Zhang Y, Liu Y, Liu Y, Tu J, Shen Y Int J Nanomedicine. 2021; 16:2443-2459.

PMID: 33814909 PMC: 8009551. DOI: 10.2147/IJN.S289228.


Arrest in the Progression of Type 1 Diabetes at the Mid-Stage of Insulitic Autoimmunity Using an Autoantigen-Decorated All- Retinoic Acid and Transforming Growth Factor Beta-1 Single Microparticle Formulation.

Phillips B, Garciafigueroa Y, Engman C, Liu W, Wang Y, Lakomy R Front Immunol. 2021; 12:586220.

PMID: 33763059 PMC: 7982719. DOI: 10.3389/fimmu.2021.586220.